EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/14/2025
Back to search
Official data from USPTO
STRATµM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
02/18/2025
Trademark type
Word
Nice classes
40, 42
Filing date
08/23/2022
Registration date
05/30/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/22/2014
First use in commerce
08/22/2014
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
KHOURI, SANI
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Adare Pharmaceuticals USA, Inc.
Adare Pharmaceuticals USA, Inc.
Representatives
C. Blair Barbieri HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasedelayed release systemsclinical manufacturing of drug formulations for others to support clinical trialsfabrication and preparation of active pharmaceutical ingredients for otherstechnology scale-up services for othersintegration of technology into manufacturing processes for othersall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectablesall for injectable delivery
Class 42
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development servicesresearch and development in the area of pharmaceutical drug delivery systemsincluding continuous releasepulsatile releaseextended releasesustained releasedelayed release systemsconsisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredientsanalytic techniques to test drug formulationsanalytic services to detectidentify and quantify drug componentsstability testingphysical characterization of drug formulationsin-vitro release testingall relating to multiple drug product formatssemi-solidssolutionssuspensionsparticulatessolid dispersionssolid solutions and injectablesall for injectable delivery
Publications
History of USPTO decisions and trademark events.
15 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/14/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/14/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/30/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2023
DOCK
ASSIGNED TO EXAMINER
02/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2022
NWAP
NEW APPLICATION ENTERED
08/26/2022
Continuous trademark protection
Get notified about every new filing that threatens STRATµM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.